 |
Technology Insight: Imaging Neurodegeneration in Parkinson's Disease CME DisclosuresRelease Date: April 1, 2008; Valid for credit through April 1, 2009 |
| Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Identify the distinguishing diagnostic feature of idiopathic Parkinson's disease (PD)
- List brain imaging techniques most suited for structural and functional investigation in PD
- Describe useful imaging techniques
for preclinical diagnosis of PD
- Identify neurotransmitters associated with depression in PD
- Describe risk factors for the development of PD
Authors and Disclosures |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
